Evidence map›Paper›PMID 26773310›Full record

ArticleCancer medicine2016

Hematologic malignancies in South Africa 2000-2006: analysis of data reported to the National Cancer Registry.

Sara J Schonfeld, Friederike Erdmann, Tracey Wiggill, Elvira Singh, Patricia Kellett, Chantal Babb, Joachim Schüz

Open access · goldAbstract readHistorical Article
In one paragraph

Article in Cancer medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Medical practitioners' knowledge and awareness of multiple myeloma at public hospitals, Gauteng, South Africa.South African family practice : official journal of the South African Academy of Family Practice/Primary Care · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Sara J SchonfeldSection of Environment and Radiation, International Agency for Research on Cancer (IARC), Lyon, France.
Friederike ErdmannSection of Environment and Radiation, International Agency for Research on Cancer (IARC), Lyon, France.
Tracey WiggillDepartment of Haematology and Molecular Medicine, National Health Laboratory Service, Johannesburg, South Africa.
Elvira SinghNational Cancer Registry, National Health Laboratory Service, Johannesburg, South Africa.
Patricia KellettNational Cancer Registry, National Health Laboratory Service, Johannesburg, South Africa.
Chantal BabbNational Cancer Registry, National Health Laboratory Service, Johannesburg, South Africa.
Joachim SchüzSection of Environment and Radiation, International Agency for Research on Cancer (IARC), Lyon, France.
Centre International de Recherche sur le Cancer · FRNational Health Laboratory Service · ZAUniversity of the Witwatersrand · ZA

Funding

World Health Organization 001
6 · The paper itself

Abstract

Little is known about the incidence patterns of hematologic malignancies in Sub-Saharan Africa, including South Africa. We estimated incidence rates of pathology-confirmed adult cases of leukemia, myeloma and related diseases (myeloma), Hodgkin lymphoma (HL), and non-Hodgkin lymphoma (NHL) reported to the National Cancer Registry of South Africa (NCR) between 2000 and 2006, by age, gender, and population group (Black, White, Coloured, Asian/Indian). Gender-specific age-standardized rates were calculated overall and by population group and incidence rate ratios (IRRs) were estimated using Poisson regression models. Between 2000 and 2006, there were 14662 cases of leukemia, myeloma, HL, and NHL reported to the registry. Incidence rates of reported hematologic malignancies were generally 20-50% higher among males than females. Our analyses suggested marked differences in the rates of reported hematologic malignancies by population group which were most pronounced when comparing the White versus Black population groups (IRRs ranging from 1.6 for myeloma to 3.8 for HL for males and females combined). Challenges related to diagnosis and reporting of cancers may play a role in the patterns observed by population group while the set-up of the NCR (pathology-based) could lead to some degree of under-ascertainment in all groups. This is the first country-wide report of the incidence of hematologic malignancies in South Africa. Despite challenges, it is important to analyze and report available national cancer incidence data to raise awareness of the cancer burden and to characterize patterns by demographic characteristics so as ultimately to improve the provision of cancer-related health care.

Indexed as

AdolescentAdultAgedAged, 80 and overFemaleHematologic NeoplasmsHistory, 21st CenturyHumansIncidenceMaleMiddle AgedPopulation SurveillanceRegistriesSouth AfricaYoung AdultHematologic neoplasmsleukemialymphomapopulation groupsSouth Africa

Identifiers

PMID26773310
PMCPMC4831292
OpenAlexW2233399393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.